omniture
药明生物 WuXi Biologics

Latest News

WuXi Biologics Congratulates OncoImmune on FDA Clearance of IND Application for Next Generation anti-CTLA-4 Antibody ONC-392

SHANGHAI, Jan. 2, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global ope...

2020-01-02 08:08 639

WuXi Biologics Receives "Special Award to Investors in Ireland" from Asia Matters

DUBLIN, Dec. 23, 2019 /PRNewswire/ -- December 23, 2019 – WuXi Biologics ("WuXi Bio") (2269.HK), a ...

2019-12-23 16:26 649

WuXi Vaccines to Build a $240 Million Manufacturing Facility in Ireland

DUNDALK, Ireland, Nov. 23, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading gl...

2019-11-23 01:55 1400

WuXi Biologics Reports Outstanding Interim Results

* 52.4% Year-on-Year Revenue Growth to RMB1,607.1 Million * Net Profit Increased 80.1% Year-on-Y...

2019-08-19 22:09 7600

WuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing

WUXI, China, June 21, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global ...

2019-06-21 08:39 2047

WuXi Biologics Signed Letter of Intent for Long-Term Vaccine Manufacturing Contract

SHANGHAI, May 21, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open...

2019-05-21 07:30 1801

WuXi Biologics Commenced Construction of a 48,000 L Integrated Manufacturing Center for Innovative Biologics in Chengdu

CHENGDU, China, May 16, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading globa...

2019-05-16 15:39 1439

WuXi Biologics Successfully Completed First FDA Routine GMP Inspection

SHANGHAI, April 17, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global op...

2019-04-17 09:14 1775

WuXi Biologics and I-Mab Biopharma Announce Long-term Strategic Manufacturing Partnership for Five Clinical and One Commercial Programs

SHANGHAI, April 16, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global op...

2019-04-16 20:00 879

WuXi Biologics and NBE-Therapeutics Announce Comprehensive ADC Development and Manufacturing Partnership

SHANGHAI and BASEL, Switzerland, April 9, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK...

2019-04-09 08:36 1234

WuXi Biologics Wins 2019 CMO Leadership Awards in All Six Core Categories

SHANGHAI and NEW YORK, April 3, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leadi...

2019-04-03 20:06 711

WuXi Biologics Receives "Asia's Best CMO of 2018" Award from IMAPAC

SHANGHAI and SINGAPORE, March 26, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (Stock Code: 226...

2019-03-26 08:24 681

WuXi Biologics Receives EMA GMP Certificates

SHANGHAI and WUXI, China, March 19, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a l...

2019-03-20 08:07 4343

WuXi Biologics Continues to Deliver Record Results

HONG KONG, March 18, 2019 /PRNewswire/ -- WuXi Biologics (Cayman) Inc. ("WuXi Biologics" or "the Gr...

2019-03-18 22:25 907

WuXi Biologics Congratulates Amicus on Receiving FDA Breakthrough Therapy Designation for AT-GAA

- The second product successfully receiving Breakthrough Therapy Designation that WuXi Biologics ...

2019-02-28 09:52 569

ABL Bio Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Novel Immune Check Point Bispecifics for $220 Million

SHANGHAI and SEOUL, Feb. 26, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading ...

2019-02-26 08:23 731

EMA Completed Pre-Approval Inspection of cGMP DS and DP Facilities for Trogarzo (TM) at WuXi Biologics

SHANGHAI, Feb. 19, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global ope...

2019-02-19 14:21 439

EMA Completed Pre-Approval Inspection of cGMP DS and DP Facilities for Trogarzo(TM) at WuXi Biologics

SHANGHAI, Feb. 19, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global ope...

2019-02-19 08:21 553

WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership

SHANGHAI and CRANBURY, N.J., Feb. 12, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a...

2019-02-12 08:04 637

WuXi Biologics and AC Immune to Establish an Exclusive Strategic Partnership

* AC Immune to draw on WuXi Biologics' expertise in manufacturing innovative New Biological Ent...

2018-12-19 20:16 644
12345